• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于乳腺癌肿瘤浸润淋巴细胞(TILs)定量解读的自动化评分方法:系统综述。

Automated scoring methods for quantitative interpretation of Tumour infiltrating lymphocytes (TILs) in breast cancer: a systematic review.

机构信息

Department of Pathology, Faculty of Medicine, The National University of Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Wilayah Persekutuan, 56000, Malaysia.

Department of Medical Diagnostic, Faculty of Health Sciences, Universiti Selangor, Jalan Zirkon A7/7, Seksyen 7, Shah Alam, Selangor, 40000, Malaysia.

出版信息

BMC Cancer. 2024 Sep 30;24(1):1202. doi: 10.1186/s12885-024-12962-8.

DOI:10.1186/s12885-024-12962-8
PMID:39350098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11440723/
Abstract

Tumour microenvironment (TME) of breast cancer mainly comprises malignant, stromal, immune, and tumour infiltrating lymphocyte (TILs). Assessment of TILs is crucial for determining the disease's prognosis. Manual TIL assessments are hampered by multiple limitations, including low precision, poor inter-observer reproducibility, and time consumption. In response to these challenges, automated scoring emerges as a promising approach. The aim of this systematic review is to assess the evidence on the approaches and performance of automated scoring methods for TILs assessment in breast cancer. This review presents a comprehensive compilation of studies related to automated scoring of TILs, sourced from four databases (Web of Science, Scopus, Science Direct, and PubMed), employing three primary keywords (artificial intelligence, breast cancer, and tumor-infiltrating lymphocytes). The PICOS framework was employed for study eligibility, and reporting adhered to the PRISMA guidelines. The initial search yielded a total of 1910 articles. Following screening and examination, 27 studies met the inclusion criteria and data were extracted for the review. The findings indicate a concentration of studies on automated TILs assessment in developed countries, specifically the United States and the United Kingdom. From the analysis, a combination of sematic segmentation and object detection (n = 10, 37%) and convolutional neural network (CNN) (n = 11, 41%), become the most frequent automated task and ML approaches applied for model development respectively. All models developed their own ground truth datasets for training and validation, and 59% of the studies assessed the prognostic value of TILs. In conclusion, this analysis contends that automated scoring methods for TILs assessment of breast cancer show significant promise for commodification and application within clinical settings.

摘要

乳腺癌的肿瘤微环境(TME)主要包括恶性、基质、免疫和肿瘤浸润淋巴细胞(TILs)。评估 TILs 对于确定疾病的预后至关重要。手动 TIL 评估受到多种限制,包括精度低、观察者间重现性差和耗时。为了应对这些挑战,自动评分方法应运而生,成为一种很有前途的方法。本系统综述旨在评估自动评分方法在乳腺癌 TIL 评估中的方法和性能的证据。

本综述全面收集了与 TIL 自动评分相关的研究,来自四个数据库(Web of Science、Scopus、Science Direct 和 PubMed),使用三个主要关键词(人工智能、乳腺癌和肿瘤浸润淋巴细胞)。采用 PICOS 框架评估研究的纳入标准,并按照 PRISMA 指南进行报告。最初的搜索共产生了 1910 篇文章。经过筛选和检查,有 27 项研究符合纳入标准,并提取数据进行综述。

研究结果表明,大多数关于自动 TILs 评估的研究集中在发达国家,特别是美国和英国。从分析中可以看出,语义分割和目标检测的组合(n=10,37%)和卷积神经网络(CNN)(n=11,41%)分别成为最常见的自动任务和用于模型开发的 ML 方法。所有开发的模型都为训练和验证建立了自己的真实数据集,59%的研究评估了 TILs 的预后价值。总之,本分析认为,乳腺癌 TILs 评估的自动评分方法在商品化和临床应用方面具有很大的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8405/11440723/aaaa3c07f354/12885_2024_12962_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8405/11440723/aaae822822e0/12885_2024_12962_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8405/11440723/d984cdbe5bfe/12885_2024_12962_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8405/11440723/270428fdcb53/12885_2024_12962_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8405/11440723/b4d81b7433fe/12885_2024_12962_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8405/11440723/aaaa3c07f354/12885_2024_12962_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8405/11440723/aaae822822e0/12885_2024_12962_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8405/11440723/d984cdbe5bfe/12885_2024_12962_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8405/11440723/270428fdcb53/12885_2024_12962_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8405/11440723/b4d81b7433fe/12885_2024_12962_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8405/11440723/aaaa3c07f354/12885_2024_12962_Fig4_HTML.jpg

相似文献

1
Automated scoring methods for quantitative interpretation of Tumour infiltrating lymphocytes (TILs) in breast cancer: a systematic review.用于乳腺癌肿瘤浸润淋巴细胞(TILs)定量解读的自动化评分方法:系统综述。
BMC Cancer. 2024 Sep 30;24(1):1202. doi: 10.1186/s12885-024-12962-8.
2
Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.肿瘤浸润淋巴细胞(TILs)的形态学评估以研究浸润性乳腺癌的免疫原性、揭示淋巴细胞网络并辅助复发预测:一项回顾性研究
Int J Mol Sci. 2017 Sep 8;18(9):1936. doi: 10.3390/ijms18091936.
3
Prognostic and predictive value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis.肿瘤浸润淋巴细胞在乳腺癌中的预后和预测价值:一项系统综述和荟萃分析
Clin Transl Oncol. 2016 May;18(5):497-506. doi: 10.1007/s12094-015-1391-y. Epub 2015 Oct 12.
4
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.浸润淋巴细胞与不同亚型乳腺癌患者预后的关系:新辅助化疗治疗 3771 例患者的汇总分析
Lancet Oncol. 2018 Jan;19(1):40-50. doi: 10.1016/S1470-2045(17)30904-X. Epub 2017 Dec 7.
5
Prognostic value of tumour-infiltrating lymphocytes based on the evaluation of frequency in patients with oestrogen receptor-positive breast cancer.基于对雌激素受体阳性乳腺癌患者浸润淋巴细胞频率评估的肿瘤浸润淋巴细胞的预后价值。
Eur J Cancer. 2021 Sep;154:217-226. doi: 10.1016/j.ejca.2021.06.011. Epub 2021 Jul 20.
6
Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study.在曲妥珠单抗和多西他赛基础上加用帕妥珠单抗或安慰剂治疗的晚期HER2阳性乳腺癌中的肿瘤浸润淋巴细胞:CLEOPATRA研究的回顾性分析
Lancet Oncol. 2017 Jan;18(1):52-62. doi: 10.1016/S1470-2045(16)30631-3. Epub 2016 Dec 7.
7
A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.肿瘤相关基质浸润淋巴细胞的数字评分可预测头颈部鳞状细胞癌的生存。
J Pathol. 2022 Feb;256(2):174-185. doi: 10.1002/path.5819. Epub 2021 Nov 24.
8
Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.肿瘤浸润淋巴细胞在不同分子亚型乳腺癌患者中的预测和预后作用:一项荟萃分析。
BMC Cancer. 2020 Nov 25;20(1):1150. doi: 10.1186/s12885-020-07654-y.
9
Optimized tumour infiltrating lymphocyte assessment for triple negative breast cancer prognostics.优化肿瘤浸润淋巴细胞评估用于三阴性乳腺癌预后。
Breast. 2021 Apr;56:78-87. doi: 10.1016/j.breast.2021.02.007. Epub 2021 Feb 17.
10
Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast.肿瘤浸润淋巴细胞对乳腺导管原位癌的预后意义。
Mod Pathol. 2018 Aug;31(8):1226-1236. doi: 10.1038/s41379-018-0040-8. Epub 2018 Mar 20.

引用本文的文献

1
Predicting Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer Using Pre-Treatment Histopathologic Images.利用治疗前组织病理学图像预测三阴性乳腺癌的新辅助化疗反应
Cancers (Basel). 2025 Jul 22;17(15):2423. doi: 10.3390/cancers17152423.
2
Predicting Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer Using Pre-Treatment Histopathologic Images.利用治疗前组织病理学图像预测三阴性乳腺癌的新辅助化疗反应
ArXiv. 2025 Jul 26:arXiv:2505.14730v2.
3
Tumor-infiltrating lymphocytes in cancer immunotherapy: from chemotactic recruitment to translational modeling.

本文引用的文献

1
Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer.基于数字图像分析和机器学习的三阴性乳腺癌新辅助化疗反应预测。
Breast Cancer Res. 2024 Jan 18;26(1):12. doi: 10.1186/s13058-023-01752-y.
2
Predicting Neoadjuvant Treatment Response in Triple-Negative Breast Cancer Using Machine Learning.使用机器学习预测三阴性乳腺癌的新辅助治疗反应
Diagnostics (Basel). 2023 Dec 28;14(1):74. doi: 10.3390/diagnostics14010074.
3
Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence.
癌症免疫治疗中的肿瘤浸润淋巴细胞:从趋化募集到转化模型
Front Immunol. 2025 May 22;16:1601773. doi: 10.3389/fimmu.2025.1601773. eCollection 2025.
4
Tumor-infiltrating lymphocytes in HER2-positive breast cancer: potential impact and challenges.HER2阳性乳腺癌中的肿瘤浸润淋巴细胞:潜在影响与挑战
ESMO Open. 2025 Feb;10(2):104120. doi: 10.1016/j.esmoop.2024.104120. Epub 2025 Jan 17.
利用人工智能评估腔面型乳腺癌中的肿瘤浸润淋巴细胞。
Br J Cancer. 2023 Nov;129(11):1747-1758. doi: 10.1038/s41416-023-02451-3. Epub 2023 Sep 30.
4
Deep learning model improves tumor-infiltrating lymphocyte evaluation and therapeutic response prediction in breast cancer.深度学习模型改善乳腺癌中肿瘤浸润淋巴细胞评估及治疗反应预测
NPJ Breast Cancer. 2023 Aug 30;9(1):71. doi: 10.1038/s41523-023-00577-4.
5
Automated Detection and Scoring of Tumor-Infiltrating Lymphocytes in Breast Cancer Histopathology Slides.乳腺癌组织病理学切片中肿瘤浸润淋巴细胞的自动检测与评分
Cancers (Basel). 2023 Jul 15;15(14):3635. doi: 10.3390/cancers15143635.
6
Multiscale deep learning framework captures systemic immune features in lymph nodes predictive of triple negative breast cancer outcome in large-scale studies.多尺度深度学习框架捕捉淋巴结中的系统性免疫特征,可预测大规模研究中三阴性乳腺癌的结局。
J Pathol. 2023 Aug;260(4):376-389. doi: 10.1002/path.6088. Epub 2023 May 25.
7
A Deep Learning Approach for Histology-Based Nucleus Segmentation and Tumor Microenvironment Characterization.深度学习方法在基于组织学的细胞核分割和肿瘤微环境特征分析中的应用。
Mod Pathol. 2023 Aug;36(8):100196. doi: 10.1016/j.modpat.2023.100196. Epub 2023 Apr 24.
8
SAMS-Net: Fusion of attention mechanism and multi-scale features network for tumor infiltrating lymphocytes segmentation.SAMS-Net:融合注意力机制和多尺度特征网络的肿瘤浸润淋巴细胞分割。
Math Biosci Eng. 2023 Jan;20(2):2964-2979. doi: 10.3934/mbe.2023140. Epub 2022 Dec 1.
9
Artificial intelligence-based digital scores of stromal tumour-infiltrating lymphocytes and tumour-associated stroma predict disease-specific survival in triple-negative breast cancer.基于人工智能的基质肿瘤浸润淋巴细胞和肿瘤相关基质数字评分可预测三阴性乳腺癌的疾病特异性生存情况。
J Pathol. 2023 May;260(1):32-42. doi: 10.1002/path.6061. Epub 2023 Feb 24.
10
Development and applications of computer image analysis algorithms for scoring of PD-L1 immunohistochemistry.用于PD-L1免疫组织化学评分的计算机图像分析算法的开发与应用
Immunooncol Technol. 2020 May 11;6:2-8. doi: 10.1016/j.iotech.2020.04.001. eCollection 2020 Jun.